Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025)
Envoy Medical (COCH) reported Amortization of Deferred Charges of $4000.0 for Q4 2025, down 98.96% on a YoY basis from $384000.0 in Q4 2024, and down 99.15% sequentially from $468000.0 in Q3 2025.
Envoy Medical (COCH) Amortization of Deferred Charges (2024 - 2025) Analysis & Trends
Envoy Medical (COCH) has 2 years of Amortization of Deferred Charges data on file, last reported at $4000.0 in Q4 2025.
- For the quarter ending Q4 2025, Amortization of Deferred Charges fell 98.96% year-over-year to $4000.0; the trailing twelve-month figure through Dec 2025 stood at $1.6 million (changed N/A YoY), and the FY2025 full-year result was $1.6 million, up 94.85% from the prior year.
- Amortization of Deferred Charges fell to $4000.0 in Q4 2025, from $468000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $623000.0 in Q2 2025 to a low of $4000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Envoy Medical | 45.50 Mn | 20.25 Mn | -274,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | 623,000.00 |
| Jun 30, 2025 | 623,000.00 |
| Mar 31, 2025 | 495,000.00 |
| Mar 31, 2025 | 495,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Dec 31, 2024 | 384,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Sep 30, 2024 | 264,000.00 |